Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis.

导出 OA

翻译打印收藏纠错

第一作者： Mark G A,Opler

第一单位： Dr. Opler is with WCG, Inc. in New York, New York.

作者： Mark G A,Opler ^[1] ; Amy,Claxton ^[2] ; James,McGrory ^[3] ; Sabina,Gasper ^[2] ; Meihua,Wang ^[2] ; Sergey,Yagoda ^[3]

作者单位： Dr. Opler is with WCG, Inc. in New York, New York. ^[1] Drs. Claxton, McGrory, Wang, and Yagoda and Ms. Gasper are with Alkermes, Inc. in Waltham, Massachusetts. ^[2] Drs. Claxton and Wang and Ms. Gasper were employees of Alkermes, Inc. at the time of the study. ^[3]

关键词 Aripiprazole lauroxil cognition function schizophrenia switch

PMID 38495608

发布时间 2024-03-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Innovations in clinical neuroscience

43-51页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis.

Innovations in clinical neuroscience

相似文献

Innovations in clinical neuroscience

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis.

Innovations in clinical neuroscience

相似文献

Innovations in clinical neuroscience

相关期刊

检索历史清除